CYP2C9 Variants Linked to Clinical Events in VTE

This article originally appeared here.
Share this content:
<i>CYP2C9</i> Variants Linked to Clinical Events in VTE
CYP2C9 Variants Linked to Clinical Events in VTE

TUESDAY, Sept. 5, 2017 (HealthDay News) -- For elderly patients treated with vitamin K antagonists for venous thromboembolism (VTE), CYP2C9 variants are associated with any clinical event, according to a study published online Aug. 22 in the Journal of Thrombosis and Haemostasis.

Michael Nagler, M.D., from Bern University Hospital in Switzerland, and colleagues examined the correlation between CYP2C9/VKORC1 variants and long-term clinical outcomes among 774 elderly patients treated with vitamin K antagonists for VTE.

Overall, 78 percent of the patients had a CYP2C9 or VKORC1 variant. The researchers found that 43.2 percent of patients had any clinical event, 15.4 percent died, 12.9 and 21.6 percent had major and non-major bleeding, respectively, and 12.9 percent had recurrent VTE. After adjustment there was a correlation for CYP2C9 variants with any clinical event (hazard ratio, 1.34; 95 percent confidence interval, 1.08 to 1.66), death (hazard ratio, 1.74; 95 percent confidence interval, 1.19 to 2.52), and clinically relevant non-major bleeding (subhazard ratio, 1.39; 95 percent confidence interval, 1.02 to 1.89), but not with major bleeding (subhazard ratio, 1.03; 95 percent confidence interval, 0.69 to 1.55) or recurrent VTE (subhazard ratio, 0.95; 95 percent confidence interval, 0.62 to 1.44). Slightly lower anticoagulation quality was seen for patients with genetic variants.

"CYP2C9 was associated with long-term overall mortality and non-major bleeding," the authors write. "While genetic variants were associated with a slightly lower anticoagulation quality, there was no relationship between genetic variants and major bleeding or VTE recurrence."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Some children may be getting meds they don't need, others may be going without drugs that may help

FDA Approves Device for Acute Coronary Artery Perforations

FDA Approves Device for Acute Coronary Artery Perforations

The PK Papyrus device is a balloon-expandable covered coronary stent and delivery system

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in injuries following implementation of federal mandatory safety standard in 2010

is free, fast, and customized just for you!




Already a member?

Sign In Now »